BECLOMETHASONE DIPROPIONATE HFA

BECLOMETHASONE DIPROPIONATE HFA was reported 2861 times

BECLOMETHASONE DIPROPIONATE HFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY ANGIOEDEMA WITH NORMAL C1 ESTERASE INHIBITOR 2 0.2222
1 DEVICE EFFECT DELAYED 1 0.2000
2 SEXUAL TRANSMISSION OF INFECTION 3 0.1304
3 ALLERGIC STOMATITIS 1 0.0909
4 DRUG DISPENSING ISSUE 1 0.0526
5 FACE CRUSHING 1 0.0435
6 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 1 0.0400
7 FOLLICULAR LYMPHOMA STAGE IV 1 0.0244
8 AIRWAY BURNS 1 0.0222
9 BRONCHIAL IRRITATION 4 0.0207
10 EYE ABRASION 1 0.0189
11 DRUG DELIVERY SYSTEM ISSUE 35 0.0177
12 HEREDITARY DISORDER 1 0.0175
13 URETHRAL DISCHARGE 2 0.0164
14 ATRIAL PRESSURE INCREASED 1 0.0132
15 PRODUCT DESIGN ISSUE 9 0.0126
16 COUGH VARIANT ASTHMA 1 0.0119
17 PRODUCT CLEANING INADEQUATE 29 0.0109
18 ALCOHOL TEST FALSE POSITIVE 1 0.0106
19 CORNEAL BLEEDING 1 0.0104
20 FOREIGN BODY IN MOUTH 1 0.0100
21 ENCAPSULATION REACTION 1 0.0097
22 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
23 BREATH ALCOHOL TEST POSITIVE 2 0.0089
24 INCREASED NEED FOR SLEEP 2 0.0086
25 DRUG DELIVERY SYSTEM REMOVAL 1 0.0083
26 ABDOMINAL WALL CYST 1 0.0082
27 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
28 DRUG DELIVERY SYSTEM MALFUNCTION 40 0.0078
29 CIRCUMORAL SWELLING 1 0.0078
30 RESPIRATORY TRACT IRRITATION 8 0.0077
31 ENDOSCOPY ABNORMAL 1 0.0075
32 DEVICE DELIVERY SYSTEM ISSUE 194 0.0071
33 FORCED EXPIRATORY VOLUME ABNORMAL 1 0.0069
34 ENTEROBIASIS 1 0.0067
35 EXPOSURE TO ALLERGEN 2 0.0063
36 CATHETER SITE WARMTH 1 0.0061
37 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 1 0.0056
38 DYSSOMNIA 1 0.0052
39 PRODUCT RESIDUE PRESENT 28 0.0052
40 CHRONIC PIGMENTED PURPURA 1 0.0051
41 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
42 EXPOSURE VIA INHALATION 1 0.0046
43 INFUSION SITE MASS 5 0.0046
44 WRONG DEVICE USED 3 0.0046
45 COLD URTICARIA 1 0.0045
46 PEAK EXPIRATORY FLOW RATE DECREASED 2 0.0045
47 DEVICE DISPENSING ERROR 5 0.0042
48 PULMONARY PAIN 12 0.0041
49 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
50 DEVICE ALLERGY 1 0.0040
51 ADENOTONSILLECTOMY 1 0.0040
52 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
53 DEVICE INEFFECTIVE 4 0.0037
54 PRODUCT DISPENSING ISSUE 16 0.0037
55 URETHRITIS 2 0.0037
56 PRODUCT TASTE ABNORMAL 50 0.0037
57 DEVICE MALFUNCTION 255 0.0036
58 AGONAL RESPIRATION 1 0.0035
59 BACTERIAL VULVOVAGINITIS 1 0.0035
60 EAR INFLAMMATION 1 0.0035
61 SACRAL PAIN 2 0.0033
62 IMPAIRED QUALITY OF LIFE 47 0.0033
63 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0032
64 PRODUCT AFTER TASTE 3 0.0031
65 ASTHMA 346 0.0031
66 VOCAL CORD DISORDER 6 0.0030
67 INFUSION SITE URTICARIA 2 0.0030
68 INFUSION SITE DISCHARGE 5 0.0028
69 BONE DEMINERALISATION 3 0.0028
70 BURNING SENSATION MUCOSAL 1 0.0028
71 CANDIDA INFECTION 44 0.0026
72 CARDIOVASCULAR SYMPTOM 1 0.0026
73 MYCOPLASMA INFECTION 2 0.0026
74 BLUE TOE SYNDROME 1 0.0026
75 OROPHARYNGEAL DISCOMFORT 23 0.0025
76 CROUP INFECTIOUS 2 0.0025
77 DEVICE DEFECTIVE 44 0.0025
78 HOUSEBOUND 1 0.0025
79 HUMIDITY INTOLERANCE 1 0.0025
80 DEATH OF RELATIVE 1 0.0025
81 EXPIRED DEVICE USED 8 0.0024
82 INFUSION SITE OEDEMA 2 0.0024
83 PRODUCT CONTAMINATION PHYSICAL 6 0.0024
84 GENITAL LESION 1 0.0024
85 INFUSION SITE IRRITATION 3 0.0023
86 HEARING AID USER 1 0.0023
87 CORONA VIRUS INFECTION 1 0.0023
88 EMERGENCY CARE 7 0.0023
89 FOREIGN BODY IN RESPIRATORY TRACT 3 0.0023
90 INFUSION SITE DISCOLOURATION 2 0.0023
91 HOMELESS 1 0.0022
92 PHARYNGEAL SWELLING 22 0.0022
93 ALLERGY TO PLANTS 1 0.0022
94 INCORRECT DOSE ADMINISTERED BY DEVICE 57 0.0022
95 EAR MALFORMATION 1 0.0022
96 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
97 INFUSION SITE HAEMORRHAGE 7 0.0021
98 HELPLESSNESS 1 0.0021
99 ANIMAL SCRATCH 2 0.0021
100 NEUROENDOCRINE CARCINOMA OF THE SKIN 2 0.0020
101 HAEMOPHILUS INFECTION 2 0.0020
102 DRAINAGE 1 0.0020
103 DEVICE ISSUE 178 0.0020
104 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0020
105 ACCIDENT AT HOME 1 0.0019
106 INFUSION SITE DISCOMFORT 2 0.0019
107 CYST REMOVAL 1 0.0019
108 DEVICE USE CONFUSION 1 0.0019
109 SLEEP DEFICIT 4 0.0019
110 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
111 TONGUE DISCOMFORT 8 0.0019
112 AUTOSCOPY 1 0.0019
113 SUPERFICIAL INJURY OF EYE 2 0.0018
114 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
115 ORAL FUNGAL INFECTION 5 0.0018
116 GENITAL DISCOMFORT 1 0.0018
117 DRUG EFFECT VARIABLE 2 0.0018
118 BURN ORAL CAVITY 1 0.0017
119 HAEMATOMA INFECTION 1 0.0017
120 PRURITUS ALLERGIC 2 0.0017
121 DEVICE MAINTENANCE ISSUE 1 0.0017
122 ADENOMYOSIS 1 0.0017
123 GLOSSITIS 6 0.0017
124 PRODUCT SUBSTITUTION ISSUE 97 0.0017
125 INFUSION SITE ERYTHEMA 14 0.0017
126 BLOOD VISCOSITY INCREASED 1 0.0017
127 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
128 EYELID SKIN DRYNESS 2 0.0016
129 ALLERGY TO METALS 1 0.0016
130 CARDIAC PROCEDURE COMPLICATION 1 0.0016
131 INFUSION SITE WARMTH 2 0.0016
132 INFUSION SITE PAIN 21 0.0016
133 POST-ACUTE COVID-19 SYNDROME 2 0.0016
134 CORNEAL PERFORATION 1 0.0016
135 INFUSION SITE PRURITUS 5 0.0016
136 ADRENAL DISORDER 3 0.0016
137 THROAT IRRITATION 69 0.0015
138 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
139 PHARYNGEAL ULCERATION 2 0.0015
140 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
141 DRY THROAT 15 0.0015
142 TONGUE DRY 2 0.0015
143 MENINGITIS VIRAL 2 0.0015
144 GENITAL SWELLING 1 0.0014
145 HAND DERMATITIS 1 0.0014
146 THERAPEUTIC PROCEDURE 2 0.0014
147 NASAL POLYPS 7 0.0014
148 FUNGAL OESOPHAGITIS 1 0.0014
149 DEVICE ELECTRICAL FINDING 1 0.0014
150 FOREIGN BODY ASPIRATION 1 0.0014
151 BACTERIAL DISEASE CARRIER 1 0.0014
152 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
153 PULMONARY FUNCTION TEST DECREASED 6 0.0014
154 INFUSION SITE INDURATION 2 0.0013
155 CHLAMYDIAL INFECTION 1 0.0013
156 BRONCHITIS BACTERIAL 1 0.0013
157 INABILITY TO AFFORD MEDICATION 13 0.0013
158 RESPIRATION ABNORMAL 9 0.0013
159 PNEUMONIA PSEUDOMONAL 2 0.0013
160 ALLERGIC COUGH 1 0.0013
161 REACTION TO EXCIPIENT 3 0.0013
162 EYE ALLERGY 2 0.0013
163 INFUSION SITE INFECTION 3 0.0013
164 VASCULAR RUPTURE 2 0.0013
165 NEOPLASM SKIN 2 0.0013
166 INFUSION SITE SWELLING 8 0.0013
167 EYELID EXFOLIATION 1 0.0013
168 DEVICE DAMAGE 1 0.0013
169 OXYGEN CONSUMPTION INCREASED 3 0.0013
170 TOTAL LUNG CAPACITY DECREASED 2 0.0013
171 DRUG PRESCRIBING ERROR 24 0.0012
172 PRODUCT ODOUR ABNORMAL 13 0.0012
173 DEVICE INFUSION ISSUE 3 0.0012
174 SEASONAL ALLERGY 17 0.0012
175 COVID-19 IMMUNISATION 1 0.0012
176 TYMPANIC MEMBRANE PERFORATION 2 0.0012
177 CHOKING 23 0.0012
178 EXPOSURE TO SARS-COV-2 2 0.0012
179 APTYALISM 1 0.0012
180 CRANIOFACIAL FRACTURE 1 0.0012
181 ADENOMA BENIGN 1 0.0012
182 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 54 0.0012
183 GENITAL BURNING SENSATION 1 0.0012
184 ABSCESS DRAINAGE 1 0.0012
185 WHEEZING 68 0.0011
186 CATHETER SITE PRURITUS 1 0.0011
187 ORAL CANDIDIASIS 15 0.0011
188 PRODUCT CONTAMINATION 4 0.0011
189 VOCAL CORD PARALYSIS 2 0.0011
190 LYMPH NODE PAIN 2 0.0011
191 BONE GRAFT 1 0.0011
192 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
193 PARANASAL SINUS DISCOMFORT 4 0.0011
194 PRODUCT PRESCRIBING ERROR 25 0.0010
195 COR PULMONALE 1 0.0010
196 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
197 DEVICE RELATED THROMBOSIS 1 0.0010
198 SYMPTOM RECURRENCE 6 0.0010
199 OBSTRUCTION 4 0.0010
200 EXPIRED PRODUCT ADMINISTERED 33 0.0010
201 EYELID PAIN 2 0.0010
202 PRODUCT SUPPLY ISSUE 7 0.0010
203 MASTICATION DISORDER 3 0.0010
204 POLYCYTHAEMIA 2 0.0010
205 DERMATITIS CONTACT 11 0.0010
206 INFUSION SITE EXTRAVASATION 6 0.0010
207 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
208 FOREIGN BODY IN THROAT 3 0.0010
209 EYE CONTUSION 2 0.0009
210 COUGH 265 0.0009
211 CATHETER SITE ERYTHEMA 2 0.0009
212 PRODUCT DELIVERY MECHANISM ISSUE 5 0.0009
213 INJECTION SITE INFECTION 3 0.0009
214 CHOKING SENSATION 5 0.0009
215 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
216 CATHETER SITE DISCHARGE 1 0.0009
217 DYSPHONIA 52 0.0009
218 HAEMOGLOBIN INCREASED 4 0.0009
219 READING DISORDER 2 0.0009
220 CORTISOL DECREASED 1 0.0009
221 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
222 ORAL PRURITUS 2 0.0009
223 CHEMICAL BURN 1 0.0009
224 SINUS PAIN 2 0.0009
225 PATELLA FRACTURE 2 0.0009
226 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
227 DERMATITIS ATOPIC 43 0.0008
228 ENDODONTIC PROCEDURE 2 0.0008
229 GLUCOSE URINE PRESENT 1 0.0008
230 CLAVICLE FRACTURE 3 0.0008
231 PRODUCT DOSE OMISSION IN ERROR 22 0.0008
232 LIPOMA 2 0.0008
233 RESPIRATORY TRACT INFECTION 20 0.0008
234 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
235 PRODUCT FORMULATION ISSUE 5 0.0008
236 NASAL DISCOMFORT 6 0.0008
237 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
238 SHOULDER ARTHROPLASTY 2 0.0007
239 HIP SURGERY 4 0.0007
240 ERYTHEMA OF EYELID 4 0.0007
241 ILLNESS 76 0.0007
242 PRODUCT PRESCRIBING ISSUE 16 0.0007
243 LIP BLISTER 2 0.0007
244 TRIGGER FINGER 3 0.0007
245 LYMPHOEDEMA 5 0.0007
246 DISCHARGE 1 0.0007
247 INSURANCE ISSUE 11 0.0007
248 SECRETION DISCHARGE 9 0.0007
249 CARDIOVERSION 1 0.0007
250 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
251 GLUTEN SENSITIVITY 1 0.0007
252 OROPHARYNGEAL PAIN 65 0.0007
253 SHOULDER OPERATION 3 0.0007
254 MIDDLE INSOMNIA 13 0.0007
255 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
256 FAT TISSUE INCREASED 1 0.0007
257 GENITAL PAIN 1 0.0007
258 CHEST DISCOMFORT 69 0.0007
259 ATYPICAL PNEUMONIA 2 0.0007
260 CENTRAL VENOUS CATHETERISATION 2 0.0007
261 EPICONDYLITIS 1 0.0007
262 CRANIOCEREBRAL INJURY 2 0.0007
263 EYE INJURY 2 0.0007
264 HEAT STROKE 1 0.0007
265 DECREASED ACTIVITY 7 0.0006
266 DAYDREAMING 1 0.0006
267 ORAL DISCOMFORT 9 0.0006
268 PHARYNGITIS STREPTOCOCCAL 7 0.0006
269 EYELIDS PRURITUS 2 0.0006
270 MULTIPLE ALLERGIES 5 0.0006
271 SWELLING OF EYELID 4 0.0006
272 MEDICATION RESIDUE PRESENT 3 0.0006
273 SKIN INFECTION 7 0.0006
274 CYSTITIS INTERSTITIAL 1 0.0006
275 SKIN EROSION 2 0.0006
276 FRUSTRATION TOLERANCE DECREASED 5 0.0006
277 PULMONARY CONGESTION 8 0.0006
278 SINUS DISORDER 12 0.0006
279 LYME DISEASE 2 0.0006
280 PRODUCT PHYSICAL ISSUE 12 0.0006
281 BRONCHIECTASIS 4 0.0006
282 SINUS CONGESTION 8 0.0006
283 EAR DISCOMFORT 6 0.0006
284 ORAL PAIN 13 0.0006
285 HYPOPNOEA 2 0.0006
286 DYSPNOEA 324 0.0006
287 DEVICE USE ISSUE 10 0.0006
288 LUNG DISORDER 28 0.0006
289 PRODUCT COMMUNICATION ISSUE 5 0.0006
290 SKIN WEEPING 2 0.0006
291 HEREDITARY ANGIOEDEMA 6 0.0006
292 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
293 FACIAL BONES FRACTURE 2 0.0006
294 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 112 0.0006
295 DEVICE ALARM ISSUE 1 0.0006
296 COVID-19 96 0.0005
297 PRODUCTIVE COUGH 26 0.0005
298 DISORGANISED SPEECH 1 0.0005
299 CYSTIC FIBROSIS 3 0.0005
300 WOUND HAEMORRHAGE 2 0.0005
301 CARDIAC DYSFUNCTION 2 0.0005
302 AURA 1 0.0005
303 OCULAR DISCOMFORT 6 0.0005
304 CHRONIC SINUSITIS 2 0.0005
305 DEVICE LEAKAGE 23 0.0005
306 SINUSITIS 54 0.0005
307 DEVICE FAILURE 8 0.0005
308 QUALITY OF LIFE DECREASED 7 0.0005
309 ECZEMA 27 0.0005
310 APHTHOUS ULCER 4 0.0005
311 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
312 THERAPEUTIC RESPONSE SHORTENED 17 0.0005
313 ORAL INFECTION 2 0.0005
314 DRUG DOSE OMISSION BY DEVICE 40 0.0005
315 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
316 SKIN ODOUR ABNORMAL 2 0.0005
317 BRADYKINESIA 3 0.0005
318 PNEUMONIA FUNGAL 2 0.0005
319 BRONCHITIS 37 0.0005
320 SENSORY LOSS 4 0.0005
321 DEVICE RELATED SEPSIS 1 0.0005
322 NASAL CONGESTION 29 0.0005
323 DEVICE DEPOSIT ISSUE 1 0.0005
324 SNEEZING 11 0.0005
325 CHANGE OF BOWEL HABIT 1 0.0005
326 ESCHERICHIA INFECTION 4 0.0005
327 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
328 PHARYNGITIS 6 0.0005
329 CHEST INJURY 1 0.0005
330 SENSATION OF FOREIGN BODY 4 0.0005
331 FEELING JITTERY 9 0.0005
332 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
333 DEREALISATION 1 0.0005
334 ABSCESS INTESTINAL 1 0.0005
335 SKIN SWELLING 4 0.0005
336 SKIN FISSURES 9 0.0005
337 WALKING AID USER 3 0.0005
338 BACTERIAL TEST POSITIVE 1 0.0004
339 CALCINOSIS 1 0.0004
340 PRODUCT USE COMPLAINT 7 0.0004
341 DISCOMFORT 27 0.0004
342 REBOUND EFFECT 5 0.0004
343 DRUG EFFECT DELAYED 2 0.0004
344 RESPIRATORY TRACT CONGESTION 7 0.0004
345 IMPAIRED GASTRIC EMPTYING 6 0.0004
346 BLOOD TESTOSTERONE DECREASED 3 0.0004
347 ABDOMINAL HERNIA 2 0.0004
348 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
349 EYE OPERATION 2 0.0004
350 EYELID DISORDER 1 0.0004
351 MUSCLE TIGHTNESS 7 0.0004
352 PRODUCT DISTRIBUTION ISSUE 4 0.0004
353 EYE SWELLING 16 0.0004
354 APHONIA 6 0.0004
355 DISCOURAGEMENT 1 0.0004
356 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
357 HAND FRACTURE 3 0.0004
358 SKIN ABRASION 2 0.0004
359 SPUTUM DISCOLOURED 4 0.0004
360 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
361 IMPAIRED WORK ABILITY 9 0.0004
362 FUNGAL INFECTION 14 0.0004
363 SUBCUTANEOUS ABSCESS 2 0.0004
364 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
365 HORMONE LEVEL ABNORMAL 2 0.0004
366 BRONCHITIS CHRONIC 1 0.0004
367 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
368 THERAPY CHANGE 4 0.0004
369 THROAT TIGHTNESS 11 0.0004
370 PANCREATIC DISORDER 2 0.0004
371 SPINAL OPERATION 5 0.0004
372 CEREBRAL DISORDER 3 0.0004
373 HYPERVOLAEMIA 2 0.0004
374 LIGAMENT SPRAIN 4 0.0004
375 MUCOUS STOOLS 2 0.0004
376 GLOSSODYNIA 9 0.0004
377 GASTROINTESTINAL TUBE INSERTION 1 0.0004
378 CATHETER SITE HAEMORRHAGE 1 0.0004
379 POOR QUALITY DEVICE USED 4 0.0004
380 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
381 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
382 CANCER PAIN 1 0.0004
383 VIRAL INFECTION 13 0.0004
384 EYE PAIN 22 0.0004
385 CATHETER SITE PAIN 1 0.0004
386 COMPARTMENT SYNDROME 1 0.0004
387 MALABSORPTION 2 0.0004
388 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
389 SARS-COV-2 TEST POSITIVE 5 0.0004
390 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
391 ANIMAL BITE 1 0.0004
392 RETCHING 8 0.0004
393 ABDOMINAL MASS 1 0.0004
394 INJECTION SITE DISCHARGE 2 0.0004
395 EAR CONGESTION 1 0.0004
396 PRODUCT DOSE OMISSION ISSUE 108 0.0004
397 JAW DISORDER 2 0.0004
398 MANIA 6 0.0004
399 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
400 ASTHENOPIA 2 0.0004
401 PRODUCT USE ISSUE 68 0.0004
402 EOSINOPHIL COUNT INCREASED 3 0.0004
403 STREPTOCOCCAL INFECTION 2 0.0004
404 EYE PRURITUS 12 0.0004
405 ENDOTRACHEAL INTUBATION 1 0.0004
406 SLEEP DISORDER 25 0.0004
407 CEREBRAL THROMBOSIS 1 0.0004
408 INTENTIONAL DOSE OMISSION 10 0.0004
409 BRONCHOSPASM 5 0.0004
410 PSEUDOMONAS INFECTION 3 0.0003
411 HYPOACUSIS 15 0.0003
412 SKIN ATROPHY 2 0.0003
413 EXERCISE TOLERANCE DECREASED 2 0.0003
414 EYE IRRITATION 20 0.0003
415 MOUTH SWELLING 2 0.0003
416 HYSTERECTOMY 3 0.0003
417 RALES 2 0.0003
418 SKIN WARM 2 0.0003
419 BILIARY COLIC 1 0.0003
420 PRODUCT LABEL CONFUSION 2 0.0003
421 DEVICE POWER SOURCE ISSUE 1 0.0003
422 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
423 DRY EYE 17 0.0003
424 PRODUCT QUALITY ISSUE 46 0.0003
425 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
426 PLEURISY 2 0.0003
427 MACULAR DEGENERATION 4 0.0003
428 WRIST FRACTURE 4 0.0003
429 GASTROENTERITIS VIRAL 6 0.0003
430 HYPERCAPNIA 1 0.0003
431 HYPOAESTHESIA ORAL 5 0.0003
432 LIMB INJURY 9 0.0003
433 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
434 DIABETIC FOOT 1 0.0003
435 INJECTION SITE RASH 10 0.0003
436 ADVERSE EVENT 30 0.0003
437 POOR QUALITY SLEEP 7 0.0003
438 FIBROSIS 1 0.0003
439 RHINORRHOEA 21 0.0003
440 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
441 INFLUENZA 36 0.0003
442 BACTERIAL INFECTION 6 0.0003
443 BRAIN FOG 5 0.0003
444 BLEPHAROSPASM 2 0.0003
445 SLEEP APNOEA SYNDROME 6 0.0003
446 HAEMOGLOBIN ABNORMAL 2 0.0003
447 POLYP 2 0.0003
448 ANHEDONIA 8 0.0003
449 EYE DISORDER 10 0.0003
450 DYSGRAPHIA 2 0.0003
451 BLADDER DISORDER 3 0.0003
452 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
453 EAR INFECTION 8 0.0003
454 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
455 ANXIETY DISORDER 1 0.0003
456 DRUG INEFFECTIVE 393 0.0003
457 DRY MOUTH 24 0.0003
458 PRODUCT LABEL ISSUE 2 0.0003
459 THERAPY INTERRUPTED 21 0.0003
460 PRODUCT DOSE OMISSION 19 0.0003
461 POOR VENOUS ACCESS 3 0.0003
462 HYPERREFLEXIA 1 0.0003
463 DEVICE DIFFICULT TO USE 19 0.0003
464 DEFAECATION URGENCY 2 0.0003
465 INJECTION SITE URTICARIA 7 0.0003
466 EAR PRURITUS 1 0.0003
467 CYSTITIS 9 0.0003
468 NASOPHARYNGITIS 52 0.0003
469 THERMAL BURN 2 0.0003
470 EATING DISORDER 6 0.0003
471 APPENDICECTOMY 1 0.0003
472 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
473 VISUAL FIELD DEFECT 2 0.0003
474 BIPOLAR DISORDER 3 0.0003
475 SKIN LACERATION 3 0.0003
476 DRUG EFFECT INCOMPLETE 10 0.0003
477 WOUND INFECTION 3 0.0003
478 ASTHMATIC CRISIS 1 0.0003
479 MAJOR DEPRESSION 2 0.0003
480 FOOD INTOLERANCE 1 0.0003
481 ORAL DISORDER 2 0.0003
482 MOUTH HAEMORRHAGE 2 0.0003
483 DENTAL CARIES 3 0.0003
484 ARTHROPOD BITE 2 0.0003
485 TOOTH DISORDER 6 0.0003
486 CONJUNCTIVITIS 5 0.0003
487 BONE DENSITY ABNORMAL 1 0.0003
488 RESPIRATORY DISORDER 8 0.0003
489 LACRIMATION INCREASED 8 0.0003
490 CHOLECYSTECTOMY 3 0.0003
491 FOOD ALLERGY 2 0.0003
492 MUSCULOSKELETAL CHEST PAIN 4 0.0003
493 GASTROINTESTINAL INFLAMMATION 2 0.0003
494 PRODUCT STORAGE ERROR 22 0.0003
495 SPINAL FRACTURE 5 0.0002
496 NERVOUSNESS 13 0.0002
497 ENURESIS 1 0.0002
498 PRODUCT ADMINISTRATION ERROR 5 0.0002
499 PAIN IN JAW 7 0.0002
500 GALLBLADDER OPERATION 1 0.0002
501 MUSCLE DISORDER 2 0.0002
502 HOMICIDAL IDEATION 1 0.0002
503 TASTE DISORDER 5 0.0002
504 BACK DISORDER 4 0.0002
505 HYPERSOMNIA 7 0.0002
506 ABNORMAL FAECES 2 0.0002
507 INFECTION 35 0.0002
508 LIP SWELLING 8 0.0002
509 SKIN EXFOLIATION 20 0.0002
510 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
511 VITAMIN D DECREASED 2 0.0002
512 PRODUCT CONTAINER ISSUE 2 0.0002
513 CARDIAC OPERATION 2 0.0002
514 ABNORMAL SENSATION IN EYE 1 0.0002
515 DEVICE OPERATIONAL ISSUE 1 0.0002
516 DISEASE RECURRENCE 11 0.0002
517 MUSCLE STRAIN 2 0.0002
518 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
519 DEAFNESS 6 0.0002
520 BURNING SENSATION 16 0.0002
521 SPINAL OSTEOARTHRITIS 2 0.0002
522 ABDOMINAL DISCOMFORT 38 0.0002
523 CATHETERISATION CARDIAC 1 0.0002
524 SWOLLEN TONGUE 7 0.0002
525 BRAIN NEOPLASM MALIGNANT 1 0.0002
526 INCORRECT DOSE ADMINISTERED 51 0.0002
527 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
528 RASH PAPULAR 5 0.0002
529 PAIN OF SKIN 6 0.0002
530 HEAVY MENSTRUAL BLEEDING 2 0.0002
531 HEART RATE IRREGULAR 5 0.0002
532 FEELING ABNORMAL 53 0.0002
533 RESTLESS LEGS SYNDROME 4 0.0002
534 OSTEOPOROSIS 9 0.0002
535 DYSURIA 8 0.0002
536 DIVERTICULITIS 6 0.0002
537 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
538 ROAD TRAFFIC ACCIDENT 9 0.0002
539 FEELING OF DESPAIR 1 0.0002
540 MALAISE 94 0.0002
541 CONDITION AGGRAVATED 65 0.0002
542 DEVICE OCCLUSION 3 0.0002
543 BLOOD URINE PRESENT 4 0.0002
544 PNEUMONIA 68 0.0002
545 SPEECH DISORDER 11 0.0002
546 ENDOMETRIOSIS 1 0.0002
547 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
548 PARAESTHESIA ORAL 3 0.0002
549 AFFECT LABILITY 2 0.0002
550 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
551 ANOSMIA 3 0.0002
552 LOCALISED INFECTION 5 0.0002
553 GUILLAIN-BARRE SYNDROME 1 0.0002
554 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
555 EAR PAIN 4 0.0002
556 VITAMIN D DEFICIENCY 2 0.0002
557 ORAL HERPES 4 0.0002
558 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
559 SURGERY 12 0.0002
560 COELIAC DISEASE 2 0.0002
561 ENCEPHALOPATHY 5 0.0002
562 BREATH SOUNDS ABNORMAL 1 0.0002
563 HOSPICE CARE 2 0.0002
564 SKIN HAEMORRHAGE 3 0.0002
565 FOOT OPERATION 1 0.0002
566 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
567 DEVICE USE ERROR 7 0.0002
568 BLOOD PRESSURE ABNORMAL 4 0.0002
569 TREATMENT NONCOMPLIANCE 11 0.0002
570 UPPER LIMB FRACTURE 4 0.0002
571 THERAPY NON-RESPONDER 9 0.0002
572 RASH MACULAR 7 0.0002
573 SALIVARY HYPERSECRETION 2 0.0002
574 CHEST PAIN 37 0.0002
575 HEADACHE 125 0.0002
576 THERAPEUTIC RESPONSE DECREASED 12 0.0002
577 EXTRA DOSE ADMINISTERED 8 0.0002
578 PRODUCT COMPLAINT 5 0.0002
579 DEVICE BREAKAGE 8 0.0002
580 PALPITATIONS 23 0.0002
581 SLUGGISHNESS 2 0.0002
582 HIP ARTHROPLASTY 3 0.0002
583 SKIN DISCOLOURATION 9 0.0002
584 INITIAL INSOMNIA 2 0.0002
585 THYROID DISORDER 3 0.0002
586 HYPERSENSITIVITY 36 0.0002
587 TEMPERATURE INTOLERANCE 2 0.0002
588 EXPOSURE VIA SKIN CONTACT 5 0.0002
589 PETECHIAE 2 0.0002
590 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
591 CATATONIA 1 0.0002
592 INJECTION SITE DISCOMFORT 2 0.0002
593 KNEE ARTHROPLASTY 4 0.0002
594 SCRATCH 2 0.0002
595 INCONTINENCE 2 0.0002
596 JOINT DISLOCATION 2 0.0002
597 DYSGEUSIA 14 0.0002
598 SCIATICA 3 0.0002
599 INJECTION SITE BRUISING 15 0.0002
600 DRY SKIN 25 0.0002
601 JOINT INJURY 4 0.0002
602 FOOD POISONING 1 0.0002
603 IRRITABLE BOWEL SYNDROME 4 0.0002
604 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
605 FEAR 5 0.0002
606 DRUG EFFECT DECREASED 10 0.0002
607 GINGIVITIS 1 0.0002
608 RASH PRURITIC 10 0.0002
609 FAECES DISCOLOURED 4 0.0002
610 BACK INJURY 2 0.0002
611 PULMONARY THROMBOSIS 2 0.0002
612 SKIN LESION 5 0.0002
613 URINARY TRACT INFECTION 31 0.0002
614 TOOTH FRACTURE 2 0.0002
615 FEELING COLD 5 0.0002
616 GAIT INABILITY 6 0.0002
617 MALNUTRITION 2 0.0002
618 BLOOD CALCIUM DECREASED 2 0.0002
619 EYE INFECTION 2 0.0002
620 FLUID RETENTION 9 0.0002
621 CONTUSION 17 0.0002
622 PRODUCT AVAILABILITY ISSUE 4 0.0002
623 CARDIAC VALVE DISEASE 1 0.0002
624 HYPERCHLORHYDRIA 1 0.0002
625 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
626 SWELLING FACE 11 0.0002
627 BLOOD IRON DECREASED 2 0.0002
628 GALLBLADDER DISORDER 3 0.0002
629 CATARACT 10 0.0002
630 HYPERLIPIDAEMIA 2 0.0002
631 BLOOD PRESSURE FLUCTUATION 4 0.0002
632 OSTEOMYELITIS 3 0.0002
633 PANIC ATTACK 6 0.0002
634 INJECTION SITE PRURITUS 11 0.0002
635 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
636 FEELING HOT 10 0.0002
637 ANAPHYLACTIC REACTION 9 0.0002
638 HEART RATE INCREASED 16 0.0002
639 AGEUSIA 4 0.0002
640 INJECTION SITE REACTION 11 0.0002
641 BONE DENSITY DECREASED 5 0.0002
642 PHOTOPHOBIA 3 0.0002
643 DYSPNOEA EXERTIONAL 6 0.0002
644 MUSCLE ATROPHY 2 0.0002
645 MIGRAINE 15 0.0002
646 PULMONARY FIBROSIS 3 0.0002
647 POST PROCEDURAL COMPLICATION 3 0.0002
648 HOSPITALISATION 24 0.0002
649 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
650 PERIPHERAL SWELLING 24 0.0002
651 INSOMNIA 41 0.0002
652 RASH 67 0.0002
653 BONE PAIN 9 0.0002
654 PRURITUS 59 0.0002
655 BRADYPHRENIA 1 0.0002
656 NEPHROLITHIASIS 7 0.0002
657 HAND DEFORMITY 2 0.0002
658 ASPERGILLUS INFECTION 1 0.0002
659 IMMUNE SYSTEM DISORDER 2 0.0002
660 TOOTH INFECTION 2 0.0002
661 CORONAVIRUS INFECTION 1 0.0002
662 APPETITE DISORDER 1 0.0002
663 ADVERSE REACTION 2 0.0002
664 SKIN DISORDER 5 0.0001
665 NEOPLASM MALIGNANT 10 0.0001
666 BREAST MASS 1 0.0001
667 STOMATITIS 9 0.0001
668 FREQUENT BOWEL MOVEMENTS 4 0.0001
669 ANGER 5 0.0001
670 OCULAR HYPERAEMIA 7 0.0001
671 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
672 INJECTION SITE ERYTHEMA 18 0.0001
673 ADVERSE DRUG REACTION 13 0.0001
674 ENCEPHALITIS 1 0.0001
675 FORMICATION 1 0.0001
676 COORDINATION ABNORMAL 2 0.0001
677 DERMATITIS 3 0.0001
678 NECK PAIN 8 0.0001
679 CARPAL TUNNEL SYNDROME 2 0.0001
680 HEART RATE DECREASED 5 0.0001
681 OXYGEN SATURATION DECREASED 8 0.0001
682 APPLICATION SITE REACTION 1 0.0001
683 BLINDNESS UNILATERAL 2 0.0001
684 DIZZINESS 70 0.0001
685 FEAR OF INJECTION 1 0.0001
686 SKIN CANCER 3 0.0001
687 HERPES ZOSTER 8 0.0001
688 CELLULITIS 7 0.0001
689 PRODUCT DISPENSING ERROR 3 0.0001
690 BLINDNESS TRANSIENT 1 0.0001
691 PULMONARY MASS 2 0.0001
692 GASTROINTESTINAL DISORDER 12 0.0001
693 ANXIETY 38 0.0001
694 BLOOD POTASSIUM DECREASED 4 0.0001
695 OSTEOPENIA 2 0.0001
696 AORTIC ANEURYSM 1 0.0001
697 DRUG DISPENSING ERROR 2 0.0001
698 BOWEL MOVEMENT IRREGULARITY 1 0.0001
699 INJECTION SITE SWELLING 10 0.0001
700 DISTURBANCE IN ATTENTION 7 0.0001
701 LYMPHOMA 2 0.0001
702 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
703 APNOEA 1 0.0001
704 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
705 BASAL CELL CARCINOMA 2 0.0001
706 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
707 AFFECTIVE DISORDER 1 0.0001
708 FATIGUE 99 0.0001
709 GINGIVAL PAIN 1 0.0001
710 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
711 RASH ERYTHEMATOUS 6 0.0001
712 URTICARIA 21 0.0001
713 ARTHRALGIA 52 0.0001
714 BLOOD DISORDER 1 0.0001
715 BLISTER 7 0.0001
716 NIGHT SWEATS 4 0.0001
717 FIBROMYALGIA 3 0.0001
718 HYPERAESTHESIA 1 0.0001
719 STAPHYLOCOCCAL INFECTION 4 0.0001
720 PHOTOSENSITIVITY REACTION 2 0.0001
721 VISUAL IMPAIRMENT 15 0.0001
722 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
723 SWELLING 11 0.0001
724 THERAPY CESSATION 6 0.0001
725 SCAR 2 0.0001
726 HYPERHIDROSIS 15 0.0001
727 MUSCULOSKELETAL DISCOMFORT 2 0.0001
728 HAEMATOMA 3 0.0001
729 PAIN 71 0.0001
730 CARDIAC MURMUR 1 0.0001
731 NAUSEA 91 0.0001
732 MENTAL DISORDER 5 0.0001
733 GRIP STRENGTH DECREASED 1 0.0001
734 HYPOXIA 4 0.0001
735 LYMPHADENOPATHY 4 0.0001
736 FACIAL PAIN 1 0.0001
737 BACK PAIN 26 0.0001
738 PULMONARY OEDEMA 5 0.0001
739 GASTROINTESTINAL INFECTION 1 0.0001
740 BLOOD PRESSURE INCREASED 17 0.0001
741 TOOTHACHE 2 0.0001
742 CONSTIPATION 24 0.0001
743 HIDRADENITIS 1 0.0001
744 EXOSTOSIS 1 0.0001
745 SKIN IRRITATION 5 0.0001
746 MUSCLE SPASMS 20 0.0001
747 BRAIN NEOPLASM 1 0.0001
748 HAEMATOCHEZIA 6 0.0001
749 BLOOD GLUCOSE ABNORMAL 2 0.0001
750 INJECTION SITE PAIN 33 0.0001
751 WEIGHT DECREASED 30 0.0001
752 WOUND 3 0.0001
753 EPISTAXIS 8 0.0001
754 HYPOAESTHESIA 16 0.0001
755 ABDOMINAL PAIN UPPER 22 0.0001
756 FLANK PAIN 1 0.0001
757 ASTHENIA 40 0.0001
758 ARTERIOSCLEROSIS 1 0.0001
759 ABDOMINAL DISTENSION 11 0.0001
760 INCREASED APPETITE 2 0.0001
761 LOWER LIMB FRACTURE 2 0.0001
762 GLAUCOMA 2 0.0001
763 DRUG INTOLERANCE 10 0.0001
764 HERNIA 2 0.0001
765 LIVER FUNCTION TEST ABNORMAL 3 0.0001
766 INTENTIONAL PRODUCT MISUSE 9 0.0001
767 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
768 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
769 MEMORY IMPAIRMENT 14 0.0001
770 URINARY INCONTINENCE 3 0.0001
771 DISABILITY 2 0.0001
772 COMPLICATION OF DEVICE INSERTION 2 0.0001
773 INJECTION SITE HAEMORRHAGE 8 0.0001
774 IRRITABILITY 6 0.0001
775 APHASIA 3 0.0001
776 FULL BLOOD COUNT DECREASED 2 0.0001
777 EMOTIONAL DISTRESS 12 0.0001
778 INJURY ASSOCIATED WITH DEVICE 2 0.0001
779 BODY TEMPERATURE INCREASED 2 0.0001
780 RIB FRACTURE 2 0.0001
781 LIMB DISCOMFORT 3 0.0001
782 TREATMENT FAILURE 8 0.0001
783 TREMOR 16 0.0001
784 EYE DISCHARGE 1 0.0001
785 PULMONARY HYPERTENSION 2 0.0001
786 FOLLICULITIS 1 0.0001
787 PARAESTHESIA 15 0.0001
788 HEAD INJURY 3 0.0001
789 MYALGIA 16 0.0001
790 CHILLS 11 0.0001
791 VOMITING 44 0.0001
792 BODY HEIGHT DECREASED 1 0.0001
793 HIP FRACTURE 3 0.0001
794 RECTAL HAEMORRHAGE 4 0.0001
795 PRURITUS GENERALISED 2 0.0001
796 ERYTHEMA 19 0.0001
797 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
798 DEPRESSION 21 0.0001
799 DIABETES MELLITUS 7 0.0001
800 MUSCULOSKELETAL STIFFNESS 8 0.0001
801 ASPIRATION 1 0.0001
802 GASTROINTESTINAL PAIN 1 0.0001
803 FLUSHING 9 0.0001
804 FALL 29 0.0001
805 TINNITUS 4 0.0001
806 LETHARGY 5 0.0001
807 CAESAREAN SECTION 1 0.0001
808 BLOOD CHOLESTEROL INCREASED 4 0.0001
809 COVID-19 PNEUMONIA 1 0.0001
810 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
811 PYREXIA 29 0.0001
812 ACCIDENT 1 0.0001
813 BURSITIS 1 0.0001
814 PRESYNCOPE 2 0.0001
815 PLEURAL EFFUSION 5 0.0001
816 ATRIAL FIBRILLATION 8 0.0001
817 DIARRHOEA 53 0.0001
818 CYST 1 0.0001
819 HAIR COLOUR CHANGES 1 0.0001
820 VISION BLURRED 11 0.0001
821 HOT FLUSH 6 0.0001
822 DERMATITIS ALLERGIC 1 0.0001
823 SOMNOLENCE 16 0.0001
824 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
825 MUSCULAR WEAKNESS 9 0.0001
826 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
827 INFLAMMATION 4 0.0001
828 NO ADVERSE EVENT 14 0.0001
829 DIPLOPIA 2 0.0001
830 CEREBROVASCULAR ACCIDENT 13 0.0001
831 PSORIASIS 10 0.0001
832 SEDATION 2 0.0001
833 MUSCULOSKELETAL PAIN 4 0.0001
834 BEDRIDDEN 1 0.0001
835 ANKYLOSING SPONDYLITIS 1 0.0001
836 ABNORMAL BEHAVIOUR 3 0.0001
837 DISORIENTATION 3 0.0001
838 DEHYDRATION 10 0.0001
839 CARDIAC DISORDER 7 0.0001
840 OEDEMA 4 0.0001
841 DYSPHAGIA 7 0.0001
842 PNEUMONITIS 2 0.0001
843 CORONARY ARTERY OCCLUSION 1 0.0001
844 OFF LABEL USE 63 0.0001
845 POLLAKIURIA 3 0.0001
846 HUNGER 1 0.0001
847 HAEMOPTYSIS 2 0.0001
848 DEMENTIA 2 0.0001
849 WITHDRAWAL SYNDROME 3 0.0001
850 PAIN IN EXTREMITY 21 0.0001
851 BLOOD TEST ABNORMAL 1 0.0001
852 FLATULENCE 4 0.0001
853 LOSS OF CONSCIOUSNESS 9 0.0001
854 BALANCE DISORDER 6 0.0001
855 SEIZURE 8 0.0001
856 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
857 DEVICE DISLOCATION 3 0.0001
858 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
859 GAIT DISTURBANCE 13 0.0001
860 LABORATORY TEST ABNORMAL 2 0.0001
861 COLON CANCER 1 0.0001
862 BONE LOSS 1 0.0001
863 JOINT SWELLING 8 0.0001
864 ALOPECIA 13 0.0001
865 ECONOMIC PROBLEM 1 0.0001
866 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
867 VERTIGO 4 0.0001
868 SUICIDAL IDEATION 6 0.0001
869 DEVICE RELATED INFECTION 1 0.0001
870 EMOTIONAL DISORDER 2 0.0001
871 ANKLE FRACTURE 1 0.0001
872 ABDOMINAL PAIN 15 0.0001
873 DELUSION 1 0.0001
874 ARTHRITIS 5 0.0001
875 PULMONARY EMBOLISM 6 0.0001
876 HALLUCINATION, AUDITORY 1 0.0001
877 MOVEMENT DISORDER 2 0.0001
878 THROMBOSIS 5 0.0001
879 BLOOD POTASSIUM INCREASED 1 0.0001
880 DYSPEPSIA 6 0.0001
881 INFUSION RELATED REACTION 4 0.0001
882 BLOOD PRESSURE DECREASED 4 0.0001
883 AGGRESSION 3 0.0001
884 WEIGHT INCREASED 13 0.0001
885 NIGHTMARE 2 0.0001
886 NEOPLASM PROGRESSION 2 0.0001
887 HAEMORRHAGE 6 0.0001
888 DEPRESSED MOOD 3 0.0001
889 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
890 HEAD DISCOMFORT 1 0.0001
891 TACHYCARDIA 5 0.0001
892 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
893 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
894 MOBILITY DECREASED 4 0.0001
895 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
896 CRYING 2 0.0001
897 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
898 RESTLESSNESS 2 0.0001
899 INJECTION SITE MASS 2 0.0001
900 ARTHROPATHY 3 0.0001
901 SEPSIS 6 0.0001
902 DYSARTHRIA 2 0.0001
903 INTESTINAL OBSTRUCTION 2 0.0001
904 BLOOD SODIUM DECREASED 1 0.0001
905 UNEVALUABLE EVENT 4 0.0001
906 FRACTURE 1 0.0001
907 COLITIS 2 0.0001
908 FOOT FRACTURE 1 0.0001
909 GASTRIC ULCER 1 0.0001
910 HYPERTENSION 11 0.0001
911 DECREASED APPETITE 12 0.0001
912 MYOCARDIAL INFARCTION 9 0.0001
913 DYSTONIA 1 0.0001
914 HAEMORRHOIDS 1 0.0001
915 PLASMA CELL MYELOMA 2 0.0001
916 SYNCOPE 5 0.0000
917 CYTOKINE RELEASE SYNDROME 1 0.0000
918 CARDIAC FAILURE CONGESTIVE 4 0.0000
919 ILL-DEFINED DISORDER 3 0.0000
920 OEDEMA PERIPHERAL 6 0.0000
921 LUNG NEOPLASM MALIGNANT 2 0.0000
922 EXPOSURE DURING PREGNANCY 3 0.0000
923 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
924 BLOOD GLUCOSE INCREASED 9 0.0000
925 PLATELET COUNT DECREASED 5 0.0000
926 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
927 AMNESIA 3 0.0000
928 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
929 HYPOTENSION 9 0.0000
930 APPLICATION SITE PRURITUS 1 0.0000
931 HEPATIC ENZYME INCREASED 3 0.0000
932 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
933 COGNITIVE DISORDER 2 0.0000
934 ARRHYTHMIA 2 0.0000
935 BLOOD GLUCOSE DECREASED 2 0.0000
936 HEPATIC CANCER 1 0.0000
937 UNDERDOSE 3 0.0000
938 AGITATION 3 0.0000
939 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
940 GASTRIC CANCER 1 0.0000
941 HEPATITIS 1 0.0000
942 HAEMOGLOBIN DECREASED 4 0.0000
943 GASTRITIS 1 0.0000
944 CARDIAC FAILURE 3 0.0000
945 DRUG DEPENDENCE 6 0.0000
946 BLOOD BILIRUBIN INCREASED 1 0.0000
947 INFLUENZA LIKE ILLNESS 3 0.0000
948 ABNORMAL DREAMS 1 0.0000
949 MEDICATION ERROR 2 0.0000
950 HYPONATRAEMIA 2 0.0000
951 RHEUMATOID ARTHRITIS 4 0.0000
952 ACUTE MYOCARDIAL INFARCTION 1 0.0000
953 DISEASE PROGRESSION 4 0.0000
954 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
955 CORONARY ARTERY DISEASE 1 0.0000
956 DRUG ADMINISTRATION ERROR 1 0.0000
957 FEMUR FRACTURE 1 0.0000
958 ANAEMIA 6 0.0000
959 DEATH 27 0.0000
960 CHOLELITHIASIS 1 0.0000
961 GASTRIC DISORDER 1 0.0000
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
963 SKIN BURNING SENSATION 2 0.0000
964 OVERDOSE 6 0.0000
965 C-REACTIVE PROTEIN INCREASED 1 0.0000
966 HYPERGLYCAEMIA 1 0.0000
967 RESPIRATORY FAILURE 2 0.0000
968 HALLUCINATION 2 0.0000
969 ACNE 2 0.0000
970 ACUTE KIDNEY INJURY 4 0.0000
971 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
972 CONFUSIONAL STATE 4 0.0000
973 DYSKINESIA 1 0.0000
974 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
975 BLINDNESS 1 0.0000
976 RENAL IMPAIRMENT 2 0.0000
977 DRUG WITHDRAWAL SYNDROME 2 0.0000
978 COLITIS ULCERATIVE 1 0.0000
979 BREAST CANCER 2 0.0000
980 DRUG INTERACTION 3 0.0000
981 BRADYCARDIA 1 0.0000
982 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
983 DRUG DOSE OMISSION 3 0.0000
984 THROMBOCYTOPENIA 2 0.0000
985 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
986 BLOOD CREATININE INCREASED 1 0.0000
987 NEUTROPENIA 2 0.0000
988 CHRONIC KIDNEY DISEASE 1 0.0000
989 DRUG ABUSE 1 0.0000